Current strategies in extending half-lives of therapeutic proteins

电流(流体) 医学 重症监护医学 工程类 电气工程
作者
Rahela Zaman,Rowshan Ara Islam,Nabilah Ibnat,Iekhsan Othman,Anuar Zaini,Chooi Yeng Lee,Ezharul Hoque Chowdhury
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:301: 176-189 被引量:308
标识
DOI:10.1016/j.jconrel.2019.02.016
摘要

Macromolecular protein and peptide therapeutics have been proven to be effective in treating critical human diseases precisely. Thanks to biotechnological advancement, a huge number of proteins and peptide therapeutics were made their way to pharmaceutical market in past few decades. However, one of the biggest challenges to be addressed for protein therapeutics during clinical application is their fast degradation in serum and quick elimination owing to enzymatic degradation, renal clearance, liver metabolism and immunogenicity, attributing to the short half-lives. Size and hydrophobicity of protein molecules make them prone to kidney filtration and liver metabolism. On the other hand, proteasomes responsible for protein destruction possess the capability of specifically recognizing almost all kinds of foreign proteins while avoiding any unwanted destruction of cellular components. At present almost all protein-based drug formulations available in market are administered intravenously (IV) or subcutaneously (SC) with high dosing at frequent interval, eventually creating dose-fluctuation-related complications and reducing patient compliance vastly. Therefore, artificially increasing the therapeutic half-life of a protein by attaching to it a molecule that increases the overall size (eg, PEG) or helps with receptor mediated recycling (eg, albumin), or manipulating amino acid chain in a way that makes it more prone towards aggregate formation, are some of the revolutionary approaches to avoid the fast degradation in vivo. Half-life extension technologies that are capable of dramatically enhancing half-lives of proteins in circulation (2-100 folds) and thus improving their overall pharmacokinetic (PK) parameters have been successfully applied on a wide range of protein therapeutics from hormones and enzymes, growth factor, clotting factor to interferon. The focus of the review is to assess the technological advancements made so far in enhancing circulatory half-lives and improving therapeutic potency of proteins.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Monicadd完成签到 ,获得积分10
1秒前
CITY111119发布了新的文献求助50
1秒前
min发布了新的文献求助10
1秒前
AJKLDJAK发布了新的文献求助10
2秒前
2秒前
Imagine发布了新的文献求助10
2秒前
何雨航发布了新的文献求助10
2秒前
panzerVI完成签到,获得积分10
2秒前
果子完成签到,获得积分20
2秒前
3秒前
3秒前
4秒前
4秒前
5秒前
茉云完成签到,获得积分10
5秒前
6秒前
晚霞跌落星河的应助被MADAO采纳,获得30
6秒前
小珂完成签到,获得积分10
7秒前
FossilGitter8发布了新的文献求助10
7秒前
英姑的应助被酷酷的冬灵采纳,获得50
7秒前
受伤白安发布了新的文献求助10
8秒前
cosscant发布了新的文献求助10
8秒前
春天完成签到 ,获得积分10
9秒前
9秒前
9秒前
10秒前
cxxxxx完成签到,获得积分10
10秒前
10秒前
10秒前
魏伯安发布了新的文献求助10
11秒前
七号楼少女完成签到,获得积分10
11秒前
科研通AI6.3的应助被qudvey采纳,获得10
11秒前
高兴星完成签到,获得积分10
11秒前
12秒前
Owen的应助被李有峰采纳,获得10
12秒前
AJKLDJAK完成签到,获得积分10
12秒前
不想打工发布了新的文献求助10
12秒前
13秒前
heinnie完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182014
求助须知:如何正确求助?哪些是违规求助? 9571728
关于积分的说明 21819478
捐赠科研通 7778441
什么是DOI,文献DOI怎么找? 3433580
关于科研通互助平台的介绍 2557781
邀请新用户注册赠送积分活动 2479640